NUTLEY, N.J., May 20, 2025 /PRNewswire/ -- Eisai announced today the presentation of clinical research across its oncology portfolio and pipeline during the 2025 American Society of Clinical ...

Mutations in vascular endothelial growth factor (VEGF) receptor-3 (VEGFR3 or FLT4) cause Milroy disease, an autosomal dominant condition that presents with congenital lymphedema. Mutations in VEGFR3 ...

the HKUMed research team identified two combinations harbouring a common target known as NMDAR1 and its paired targets are two kinases (FLT4 and FGFR3) of which both their corresponding drug ...

In contrast, young patients had a 40% and 44% decreased odds of presenting with KDR and FLT4 nonsilent mutations, respectively, compared with patients with late-onset non-hypermutated CRC (KDR: ...

In this case study, we describe the first instance of ALK rearrangement in CRC detected using NGS of CSF ctDNA, as well as a case of lasting objective tumor response to crizotinib, alectinib, and ...